Evotec offers fully integrated antiviral drug discovery solutions designed to accelerate the path from target to IND. With deep expertise in virology, immunology, and translational sciences, our multidisciplinary teams develop host-targeting and direct-acting antivirals across diverse viral families - from respiratory and chronic infections to emerging pathogens. Supported by state-of-the-art screening technologies, BSL2–BSL3 facilities, and validated in vivo models, Evotec partners with you to uncover and advance innovative antiviral therapeutics that address the world’s most urgent infectious disease challenges.